论文信息 - A phase II study of palbociclib for recurrent or refractory advanced thymic epithelial tumors (KCSG LU17-21). - 字舞流文

A phase II study of palbociclib for recurrent or refractory advanced thymic epithelial tumors (KCSG LU17-21).

J. Ahn | M. Ahn | Keunchil Park | Joo‐Hang Kim | H. Kim | Se-Hoon Lee | Jong-Mu Sun | H. Jung | K. Park | B. Ku | Sehhoon Park | Miso Kim | Jinhyun Cho | Ji Hyun Park | Yoon Hee Choi